Physiologically Based in Silico Models for the Prediction of Oral Drug Absorption

The ability to accurately predict the oral absorption of drugs based solely on in vitro data provides an opportunity to assess the developability, from an absorption point of view, of new chemical entities before any preclinical or clinical in vivo studies are performed. There have been several reports on physiologically based mathematical models that are capable of producing such predictions, and there are a few commercially available software packages (e.g., GastroPlus™, iDEA™, Intellipharm®PK, and PK-Sim®) that have been shown to predict the human absorption properties with a fairly high degree of accuracy. As these models use the interplay between the drug characteristics and the human physiology to simulate the processes involved in the oral absorption of drugs, they also give information about the underlying mechanisms for absorption limitations and as such they are well suited to be used in progressing new chemistry and to support formulation development. The aim of this chapter is to briefly summarize the underlying principles for some of the physiologically based in silico models for the prediction of human absorption and to discuss their relative performance as well as limitations in their use.

[1]  Christos Reppas,et al.  Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms , 2004, Pharmaceutical Research.

[2]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[3]  Anne Hersey,et al.  Rate-Limited Steps of Human Oral Absorption and QSAR Studies , 2002, Pharmaceutical Research.

[4]  Lawrence X. Yu,et al.  In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome. , 2004, Current opinion in drug discovery & development.

[5]  G. Grass,et al.  Physiologically-based pharmacokinetic simulation modelling. , 2002, Advanced drug delivery reviews.

[6]  Hans Lennernäs,et al.  The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids , 2005, Pharmaceutical Research.

[7]  Hans Lennernäs,et al.  Comparison Between Permeability Coefficients in Rat and Human Jejunum , 1996, Pharmaceutical Research.

[8]  S. Nylander,et al.  Jejunal Permeability: A Comparison Between the Ussing Chamber Technique and the Single-Pass Perfusion in Humans , 1997, Pharmaceutical Research.

[9]  Jörg Lippert,et al.  From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools , 2005, Expert opinion on drug metabolism & toxicology.

[10]  Gilles Klopman,et al.  ADME evaluation. 2. A computer model for the prediction of intestinal absorption in humans. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[11]  Thomas J. Vidmar,et al.  Predicting Drug Absorption: How Nature Made It a Difficult Problem , 2002, Journal of Pharmacology and Experimental Therapeutics.

[12]  G. Amidon,et al.  Absorption potential: estimating the fraction absorbed for orally administered compounds. , 1985, Journal of pharmaceutical sciences.

[13]  Anette Müllertz,et al.  A Comparison of the Solubility of Danazol in Human and Simulated Gastrointestinal Fluids , 2000, Pharmaceutical Research.

[14]  Anette Müllertz,et al.  Dissolution of Hydrocortisone in Human and Simulated Intestinal Fluids , 2000, Pharmaceutical Research.

[15]  Christos Reppas,et al.  Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects , 2004, The Journal of pharmacy and pharmacology.

[16]  G L Amidon,et al.  Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. , 1996, Advanced drug delivery reviews.

[17]  W. Curatolo,et al.  Physical chemical properties of oral drug candidates in the discovery and exploratory development settings , 1998 .

[18]  Joe Palandra,et al.  Predicting Oral Absorption of Drugs: A Case Study with a Novel Class of Antimicrobial Agents , 2003, Pharmaceutical Research.

[19]  Lawrence X. Yu,et al.  Characterization of small intestinal transit time distribution in humans , 1998 .

[20]  Anand Balakrishnan,et al.  Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity. , 2004, Journal of pharmaceutical sciences.

[21]  K. Higaki,et al.  Prediction of the Plasma Concentration Profiles of Orally Administered Drugs in Rats on the Basis of Gastrointestinal Transit Kinetics and Absorbability , 1997, The Journal of pharmacy and pharmacology.

[22]  Lawrence X. Yu An Integrated Model for Determining Causes of Poor Oral Drug Absorption , 1999, Pharmaceutical Research.

[23]  Gordon L. Amidon,et al.  Estimating the Fraction Dose Absorbed from Suspensions of Poorly Soluble Compounds in Humans: A Mathematical Model , 1993, Pharmaceutical Research.

[24]  Christel A. S. Bergström,et al.  In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption. , 2005, Basic & clinical pharmacology & toxicology.

[25]  Anne Hersey,et al.  Evaluation of rat intestinal absorption data and correlation with human intestinal absorption. , 2003, European journal of medicinal chemistry.

[26]  A. Beresford,et al.  ADME/PK as part of a rational approach to drug discovery. , 2000, Drug discovery today.

[27]  Patrick J. Sinko,et al.  Predicting Fraction Dose Absorbed in Humans Using a Macroscopic Mass Balance Approach , 1991, Pharmaceutical Research.

[28]  G Beck,et al.  Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.

[29]  W. Schmitt,et al.  A Physiologic Model for Simulating Gastrointestinal Flow and Drug Absorption in Rats , 2003, Pharmaceutical Research.

[30]  W. Tong,et al.  Impact of solid state properties on developability assessment of drug candidates. , 2004, Advanced drug delivery reviews.

[31]  R. Löbenberg,et al.  Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs , 1998, Pharmaceutical Research.

[32]  Kevin C. Johnson,et al.  Guidance in the Setting of Drug Particle Size Specifications to Minimize Variability in Absorption , 1996, Pharmaceutical Research.

[33]  B Agoram,et al.  Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.

[34]  P J Sinko,et al.  Development of predictive pharmacokinetic simulation models for drug discovery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[35]  Thierry Lavé,et al.  Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[36]  Lawrence X. Yu,et al.  Predicting Oral Drug Absorption in Humans , 1999 .

[37]  J. Dressman,et al.  Mixing-tank model for predicting dissolution rate control or oral absorption. , 1986, Journal of pharmaceutical sciences.

[38]  Gordon L Amidon,et al.  Dissolution and Solubility Behavior of Fenofibrate in Sodium Lauryl Sulfate Solutions , 2005, Drug development and industrial pharmacy.

[39]  Paul W. Buehler,et al.  Comparison of Oral Absorption and Bioavailability of Drugs Between Monkey and Human , 2002, Pharmaceutical Research.

[40]  A. Barve,et al.  Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and Rats , 1998, Pharmaceutical Research.

[41]  H Lennernäs,et al.  Human intestinal permeability. , 1998, Journal of pharmaceutical sciences.

[42]  W. L. Chiou,et al.  Similarity in the linear and non-linear oral absorption of drugs between human and rat. , 2000, International journal of clinical pharmacology and therapeutics.

[43]  P Langguth,et al.  Intestinal drug efflux: formulation and food effects. , 2001, Advanced drug delivery reviews.

[44]  Walter Schmitt,et al.  A physiological model for the estimation of the fraction dose absorbed in humans. , 2004, Journal of medicinal chemistry.

[45]  Lawrence X. Yu,et al.  Compartmental transit and dispersion model analysis of small intestinal transit flow in humans , 1996 .

[46]  H Lennernäs,et al.  Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. , 1998, Journal of medicinal chemistry.

[47]  Elizabeth M. Topp,et al.  Transport processes in pharmaceutical systems , 1999 .

[48]  R. J. Hintz,et al.  The effect of particle size distribution on dissolution rate and oral absorption , 1989 .

[49]  G L Amidon,et al.  A compartmental absorption and transit model for estimating oral drug absorption. , 1999, International journal of pharmaceutics.

[50]  Gordon L Amidon,et al.  A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals , 2002, Journal of clinical pharmacology.

[51]  Kazutaka Higaki,et al.  Gastrointestinal transit and drug absorption. , 2000, Biological & pharmaceutical bulletin.

[52]  Kevin C. Johnson,et al.  Dissolution and Absorption Modeling: Model Expansion to Simulate the Effects of Precipitation, Water Absorption, Longitudinally Changing Intestinal Permeability, and Controlled Release on Drug Absorption , 2003, Drug development and industrial pharmacy.

[53]  Kevin C. Johnson,et al.  Dissolution Modeling: Factors Affecting the Dissolution Rates of Polydisperse Powders , 1993, Pharmaceutical Research.

[54]  G. Grass,et al.  Simulation models to predict oral drug absorption from in vitro data , 1997 .

[55]  G L Amidon,et al.  Saturable small intestinal drug absorption in humans: modeling and interpretation of cefatrizine data. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[56]  C. Lipinski Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[57]  H Lennernäs,et al.  Membrane transport of drugs in different regions of the intestinal tract of the rat. , 1998, Journal of pharmaceutical sciences.

[58]  Kjell Johnson,et al.  Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery. , 2004, International journal of pharmaceutics.

[59]  Michael B. Bolger,et al.  The composite solubility versus pH profile and its role in intestinal absorption prediction , 2008, AAPS PharmSci.

[60]  J. Votano,et al.  Recent uses of topological indices in the development of in silico ADMET models. , 2005, Current opinion in drug discovery & development.

[61]  K. Luthman,et al.  Caco-2 monolayers in experimental and theoretical predictions of drug transport. , 2001, Advanced drug delivery reviews.

[62]  Hyunyoung Jeong,et al.  Evaluation of Using Dog as an Animal Model to Study the Fraction of Oral Dose Absorbed of 43 Drugs in Humans , 2000, Pharmaceutical Research.